BRAINCODE for Cognitive Impairment Diagnosis in Older Adults: Designing a Case-Control Pilot Study
Pedro Rocha1,2, Paulina Clara Dagnino3, Ronan O'Sullivan4
1Departamento de Ciências do Comportamento, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
Summary
BRAINCODE technology uses EEG biomarkers for early detection of cognitive impairment in older adults. This pilot study aims to validate its accuracy against standard methods for diagnosing neurocognitive disorders.
Area of Science:
- Neuroscience
- Biomarkers
- Gerontology
Background:
- Early diagnosis of neurocognitive disorders benefits patients, families, and healthcare systems.
- Current diagnostic methods can be improved for accuracy and cost-effectiveness.
Purpose of the Study:
- To validate the efficacy of the BRAINCODE technology for assessing cognitive impairment in older adults.
- To establish guidelines for future research and integration into the SHAPES platform.
- To compare BRAINCODE's diagnostic performance against established clinical and neuropsychological assessments.
Main Methods:
- Pilot study design evaluating BRAINCODE's EEG biomarker analysis.
- Comparison of BRAINCODE results with standard clinical diagnosis and neuropsychological tests.
- Assessment of differentiation between normal cognition, mild cognitive impairment, and dementia.
Main Results:
- The study is designed to confirm BRAINCODE's ability to accurately discriminate cognitive states.
- Expected to show BRAINCODE differentiates normal cognitive decline from pathological conditions.
- Anticipated to differentiate mild cognitive impairment from dementia in the elderly population.
Conclusions:
- BRAINCODE shows promise as an accurate and cost-effective tool for early neurocognitive disorder diagnosis.
- Validation of BRAINCODE can support clinical decision-making and healthcare system sustainability.
- Further studies will refine BRAINCODE's integration and application in geriatric care.
Keywords:
EEG diagnosisdementiadigital healthhealthy ageingmedical devicesmild cognitive impairmentneurocognitive disordersMore Related Videos
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...